Difference between revisions of "Part:BBa K3999001"
(→Properties:) |
(→Origin: Synthetic) |
||
Line 9: | Line 9: | ||
====Base Pairs:1482bp==== | ====Base Pairs:1482bp==== | ||
====Origin: Synthetic==== | ====Origin: Synthetic==== | ||
− | ==== Properties: | + | ==== Properties:the coding sequence of the tryptophan decarboxylase (TDC). ==== |
− | + | ||
===Usage and Biology=== | ===Usage and Biology=== |
Revision as of 10:51, 21 October 2021
TDC
TDC
Profile
Name: TDC
Base Pairs:1482bp
Origin: Synthetic
Properties:the coding sequence of the tryptophan decarboxylase (TDC).
Usage and Biology
In our project, TDC is used to catalyze 5-Hydroxytryptophan (5-HTP) to serotonin (5-hydroxytryptamine, 5-HT). In normal dopamine and serotonin (5-HT) neurotransmitter synthesis, AADC is not the rate-limiting step in either reaction. However, AADC becomes the rate-limiting step of dopamine synthesis in patients treated with L-DOPA (such as in Parkinson's disease), and the rate-limiting step of serotonin synthesis in people treated with 5-HTP (such as in mild depression or dysthymia). AADC is inhibited by carbidopa outside of the blood-brain barrier to inhibit the premature conversion of L-DOPA to dopamine in the treatment of Parkinson's.
Experiment Data
Line 1: pTRC99K-vector, control plasmid, 4167bp
Line 2: recombinant plasmid pTRC99K-TDC-TPH-1, incorrect
Line 3: recombinant plasmid pTRC99K-TDC-TPH-2, 7077bp, correct
Line 4: control plasmid, 6379bp
Gel electrophoresis of recombinant plasmid pTRC99K- TDC-TPH shows that the size of pTRC99K-TDC-TPH-2 is correct.
In theory, the expression of inserted coding sequence must be induced by IPTG. However, experiment data shows that protein can express successfully regardless of whether there is IPTG induction.
Lane 1: Culture supernatant with induction (40 μL);
Lane 2: Culture supernatant without induction (40 μL);
Lane 3: Without samples
Lane 4: Supernatant of cell lysate with induction (40 μL);
Lane 5: Supernatant of cell lysate without induction (40 μL);
Lane 6: Pellet of cell lysate with induction (40 μL);
Lane 7: Pellet of cell lysate without induction (40 μL);
Lane 8: Supernatant of cell lysate with induction (20 μL);
Lane 9: Supernatant of cell lysate without induction (20 μL);
We got two bands 43.53kDa (TPH) and 53.55kDa (TDC) in both supernatant of cell lysate and pellet of cell lysate. These results suggest that TPH and TDC proteins can be expressed successfully regardless of IPTG induction.
Reference
(1)Gillman, P. K. (2009, January 29). BPS Publications. British Pharmacological Society | Journals. https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1038/sj.bjp.0707253#b88.
(2)J, N. D., S, A., J, N., J, S., A, B., & S, F. (1999, July 9). Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. https://pubmed.ncbi.nlm.nih.gov/10523062/.
(3)V, R. M., & Z, P. W. (1999, June 19). Metabolism of tricyclic antidepressants. Cellular and molecular neurobiology. https://pubmed.ncbi.nlm.nih.gov/10319193/.
(4)Gillman, P. K. (2009, January 29). BPS Publications. British Pharmacological Society | Journals. https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1038/sj.bjp.0707253.
(5)PJ;, H. C. J. D. R. S. C. (2017, May 4). How do antidepressants work? New perspectives for refining future treatment approaches. The lancet. Psychiatry. https://pubmed.ncbi.nlm.nih.gov/28153641/.
(6)Shulman, K. I., Herrmann, N., & Walker, S. E. (2013, August 10). Current Place of Monoamine Oxidase Inhibitors in the Treatment of Depression. CNS Drugs. https://link.springer.com/article/10.1007/s40263-013-0097-3.
(7)Du, Y., Gao, X.-R., Peng, L., & Ge, J.-F. (2020). Crosstalk between the microbiota-gut-brain axis and depression. Heliyon, 6(6). https://doi.org/10.1016/j.heliyon.2020.e04097
(8)Nozawa, K., Kawabata-Shoda, E., Doihara, H., Kojima, R., Okada, H., Mochizuki, S., Sano, Y., Inamura, K., Matsushime, H., Koizumi, T., Yokoyama, T., & Ito, H. (2009). TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proceedings of the National Academy of Sciences, 106(9), 3408–3413. https://doi.org/10.1073/pnas.0805323106
(9)[1] Côté F, Thévenot E, Fligny C, Fromes Y, Darmon M, Ripoche MA, et al. (November 2003). "Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function". Proceedings of the National Academy of Sciences of the United States of America. 100 (23): 13525–30. Bibcode:2003PNAS..10013525C. doi:10.1073/pnas.2233056100. PMC 263847. PMID 14597720.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 319
- 21INCOMPATIBLE WITH RFC[21]Illegal XhoI site found at 340
Illegal XhoI site found at 850 - 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]